Research programme: gamma-butyrobetaine hydroxylase inhibitors - GrindeksAlternative Names: GBB hydroxyls inhibitors - Grindeks
Latest Information Update: 29 Oct 2014
At a glance
- Originator Grindeks
- Class Small molecules
- Mechanism of Action Mixed function oxygenase inhibitors; Partial fatty acid oxidation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cardiovascular disorders
Most Recent Events
- 01 Apr 2014 Preclinical trials in Cardiovascular disorders in Latvia (unspecified route)